CEFUROXIME SODIUM

Search structure
Trade Names:
Synonyms:
Status: Approved (1983)
Entry Type: Small molecule
Molecule Category: Salt
UNII: R8A7M9MY61
Parent Compound: CEFUROXIME

Structure
InChI Key URDOHUPGIOGTKV-JTBFTWTJSA-M
Smile CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(COC(N)=O)CS[C@H]12)c1ccco1.[Na+]
InChI
InChI=1S/C16H16N4O8S.Na/c1-26-19-9(8-3-2-4-27-8)12(21)18-10-13(22)20-11(15(23)24)7(5-28-16(17)25)6-29-14(10)20;/h2-4,10,14H,5-6H2,1H3,(H2,17,25)(H,18,21)(H,23,24);/q;+1/p-1/b19-9-;/t10-,14-;/m1./s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C16H15N4NaO8S
Molecular Weight 446.37
AlogP -0.54
Hydrogen Bond Acceptor 9.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 7.0
Polar Surface Area 173.76
Molecular species ACID
Aromatic Rings 1.0
Heavy Atoms 29.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Bacterial penicillin-binding protein inhibitor
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Phosphatase Protein Phosphatase Serine/threonine protein phosphatase
- 2086 - - -
Enzyme Transferase
- - - -
Epigenetic regulator Eraser Histone deacetylase HDAC class IIb
- - - - -44.78--1.98
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC21/SLCO family of organic anion transporting polypeptides
- - - - 64.47

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Osteomyelitis 1 D010019 ClinicalTrials

Related Entries

Scaffolds

Parent

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Immune system disorders
11.45
Vascular disorders
10.44
Eye disorders
10.28
Skin and subcutaneous tissue disorders
8.37
Injury, poisoning and procedural complications
8.03
Cardiac disorders
6.87
Nervous system disorders
6.74
General disorders and administration site conditions
6.64
Respiratory, thoracic and mediastinal disorders
5.79
Gastrointestinal disorders
5.42
Infections and infestations
3.44
Investigations
3.12
Psychiatric disorders
2.38
Blood and lymphatic system disorders
2.18
Renal and urinary disorders
2.18

Cross References

Resources Reference
ChEBI 3517
ChEMBL CHEMBL2146124
FDA SRS R8A7M9MY61
KEGG C08108
PubChem 23670318
SureChEMBL SCHEMBL719536
ZINC ZINC03871978
CONTENTS